Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00755_DB01132_nanopub.RAuYpEs5X4vO2OjwmNgtS14_dGIir0VQKHCw7WUZQFM4U#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00755_DB01132 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00755_DB01132 label "DDI between Tretinoin and Pioglitazone - The moderate CYP2C8 inhibitor, Pioglitazone, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Pioglitazone is initiated, discontinued to dose changed. [drugbank_resource:DB00755_DB01132]" assertion.
- drugbank_resource:DB00755_DB01132 identifier "drugbank_resource:DB00755_DB01132" assertion.
- drugbank_resource:DB00755_DB01132 title "DDI between Tretinoin and Pioglitazone - The moderate CYP2C8 inhibitor, Pioglitazone, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Pioglitazone is initiated, discontinued to dose changed." assertion.
- drugbank:DB00755 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00755_DB01132 assertion.
- drugbank:DB01132 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00755_DB01132 assertion.